Cahill Represents Lead Arrangers in $200 Million Credit Facility for BioMarin Pharmaceutical Inc.
Date: 10/19/18
Cahill represented the lead arrangers in connection with a $200,000,000 revolving credit facility for BioMarin Pharmaceutical Inc., a global biotechnology company focused on developing and commercializing therapies for people with serious and life-threatening rare diseases and medical conditions. Proceeds from the facility will be used for general corporate purposes.